Uncategorized

… (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary … … a supplement containing conjugated linoleic acid on dairy performance, milk fatty acid composition, and adipose tissue reactivity to lipolytic challenge in mid … … analogs of lysolecithin and their use in a continuous spectrophotometric […]

Anti-obesogenic and antidiabetic effects of plants and mushrooms Medicinal plants and phytochemicals with anti-obesogenic potentials: A review The anti-obesogenic effects of dietary berry fruits: A review Potential of enhancing anti-obesogenic agriceuticals by applying sustainable fertilizers during plant cultivation Mechanisms of action for the anti-obesogenic activities of phytochemicals The anti-obesogenic effects and underpinning mechanisms of fermented

Of mice and men: The physiological role of adipose triglyceride lipase (ATGL) Hints on ATGL implications in cancer: beyond bioenergetic clues Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl) Recent advances on the role of ATGL in cancer Unique regulation of adipose triglyceride lipase (ATGL) by

The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta A new pancreatic lipase inhibitor from Broussonetia kanzinoki Quercetin is a promising pancreatic lipase inhibitor in reducing fat absorption in vivo Weight Gain Reduction in Mice Fed Panax

Possible anti-obesity therapeutics from nature–A review Anti-obesity drugs: past, present and future Anti-obesity drugs: a review about their effects and safety Anti-obesity action of oolong tea Anti-obesity therapies The obesity pipeline: current strategies in the development of anti-obesity drugs The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile Anti-obesity drugs: a

GSK3 inhibitors: development and therapeutic potential The conundrum of GSK3 inhibitors: is it the dawn of a new beginning? Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes GSK3 inhibitors and disease GSK3 inhibitors show benefits in an Alzheimer’s disease (AD) model of neurodegeneration but adverse effects in control animals GSK3

SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells Cardiovascular effects of a novel SIRT 1 activator, SRT 2104, in otherwise healthy cigarette smokers The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused

AMPK activation: a therapeutic target for type 2 diabetes? AMPK activators–potential therapeutics for metabolic and other diseases AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure Choreography of AMPK activation Use of cells expressing γ subunit variants to identify diverse mechanisms of AMPK activation Identification and characterization of a

Molecular mechanism of nrf2 activation by oxidative stress The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress Natural Nrf2 activators in diabetes Nrf2 activation as target to implement therapeutic treatments Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation Mechanism of chemical activation of Nrf2 Therapeutic potential of

Immunoregulatory functions of mTOR inhibition Dissecting the role of mTOR: lessons from mTOR inhibitors Updates of mTOR inhibitors mTOR inhibitors: an overview The pharmacology of mTOR inhibition Current development of mTOR inhibitors as anticancer agents Functional consequences of mTOR inhibition mTOR inhibitors in the treatment of cancer Will mTOR inhibitors make it as cancer drugs?